about
Protective effects of incensole acetate on cerebral ischemic injury.Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disordersGinsenoside Rb3 protects cardiomyocytes against ischemia-reperfusion injury via the inhibition of JNK-mediated NF-κB pathway: a mouse cardiomyocyte modelInflammation & apoptosis in spinal cord injuryMinocycline as a neuroprotective agent.Diabetic neuropathy: cellular mechanisms as therapeutic targets.Protective effects of ginsenoside Rb(3) on oxygen and glucose deprivation-induced ischemic injury in PC12 cells.Gypenoside Protects Cardiomyocytes against Ischemia-Reperfusion Injury via the Inhibition of Mitogen-Activated Protein Kinase Mediated Nuclear Factor Kappa B Pathway In Vitro and In Vivo.Paraquat-induced apoptosis in human neuroblastoma SH-SY5Y cells: involvement of p53 and mitochondria.Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouseNeutralization of tumor necrosis factor-related apoptosis-inducing ligand reduces spinal cord injury damage in mice.Neuroprotective effect of KR-31378, a novel potassium channel activator, on spinal cord ischemic injury in rabbits.Anti-apoptotic effect of taxodione on serum/glucose deprivation-induced PC12 cells death.Hexahydrocurcumin protects against cerebral ischemia/reperfusion injury, attenuates inflammation, and improves antioxidant defenses in a rat stroke model.Correlations between folate, B12, homocysteine levels, and radiological markers of neuropathology in elderly post-stroke patients.Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-κB pathway.
P2860
Q34250174-C866052A-FC08-41B7-8F84-2B792C6F757CQ35197096-776488B5-F976-4FDF-B13C-256B03F0EFC4Q35217141-D2CE7346-198A-44D8-A072-FD24FF277F88Q35993239-9F4372EB-5C5F-420F-9AD1-FD4EB781D97EQ36215217-43C56C7B-9B38-4EAE-BEDF-965126E1F84CQ37930962-7D8EF965-EEA3-4F61-A06B-8254655D7FF9Q39013296-D807A2EB-226C-4886-8FEB-A4C436BAEA38Q39676171-8E476356-29CC-4CA1-AA0B-6D8060BEAE24Q40016001-EFD34FFE-B9FD-40E7-8B6D-226EF15DC2B7Q40967475-DE1319B0-4755-46CC-AA81-57313C843C08Q42682239-431723EF-0018-44B5-8BA3-9B017FFE8B82Q46828610-79F08558-7E53-42F9-B4E5-F9470FF5080FQ46843437-5411FFF3-85DC-45D4-9348-3F4B3B522CB6Q47116983-415E24CB-1228-47D5-B0AC-583D6B01A6B3Q48103362-53F5E819-A6B5-4AEF-906E-B793D4F7974AQ51764245-0DAF9620-6408-4E76-AD23-AB6491B24556
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Apoptosis in acute and chronic neurological disorders.
@ast
Apoptosis in acute and chronic neurological disorders.
@en
type
label
Apoptosis in acute and chronic neurological disorders.
@ast
Apoptosis in acute and chronic neurological disorders.
@en
prefLabel
Apoptosis in acute and chronic neurological disorders.
@ast
Apoptosis in acute and chronic neurological disorders.
@en
P356
P1476
Apoptosis in acute and chronic neurological disorders.
@en
P2093
Oleksandr Ekshyyan
Tak Yee Aw
P304
P356
10.2741/1357
P577
2004-05-01T00:00:00Z